Ballentine Partners, LLC Pacific Biosciences Of California, Inc. Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q3 2024
A detailed history of Ballentine Partners, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 25,307 shares of PACB stock, worth $45,552. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,307Holding current value
$45,552% of portfolio
0.0%Shares
16 transactions
Others Institutions Holding PACB
# of Institutions
253Shares Held
228MCall Options Held
745KPut Options Held
1.23M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.4MShares$60.1 Million0.54% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$42.5 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$42.1 Million6.35% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V820.3MShares$36.6 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$31.8 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $405M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...